Brain barrier structure of APPSWE Tg2576 mice

CUI Zhan-jun LIU Fang ZHAO Kai-bing LI Bing-mei LIU Zhong-hua*

doi:10.16098/j.issn.0529-1356.2018.05.002

PDF(1211 KB)

Acta Anatomica Sinica ›› 2018, Vol. 49 ›› Issue (5) : 571-578. DOI: 10.16098/j.issn.0529-1356.2018.05.002

Neurobiology

Brain barrier structure of APPSWE Tg2576 mice

CUI Zhan-jun¹ LIU Fang² ZHAO Kai-bing³ LI Bing-mei⁴ LIU Zhong-hua ^1*

Author information +

History +

Abstract

Objective To investigate the basic structure of the blood brain barrier (BBB) and blood cerebrospinal fluid barrier (BCSFB) in mice and their changes in structure, function, and ultrastructure during the development and progression of AD. Methods The APPSWE Tg2576 mice were used and divided into APPSWE transgenic positive mice (model group) and littermates wild type mice (control group), twety mice in each group. After 16 months of feeding, whole body perfusion was performed and the craniotomy was performed to obtain the lateral ventricle wall and its choroid plexus. Immunofluorescence and transmission electron microscopy were used to observe the ultrastructure of BBB and BCSFB, so as to observe the changes of brain barrier of AD model. Results The vascular density was significantly lower in the AD model group than in the control group; the normal structure of the brain barrier in AD mice was impaired, mainly due to the connection between the brain vascular endothelial cells (or choroid plexus endothelial cells) and their organelles being damaged. The ultrastructure of the choroid plexus also showed significant changes. The main manifestations were the widening of the intercellular space, and some of the connecting structures between the cells, such as adhesion and connection, and some vesicle-like structures in the cytoplasm. Conclusion Compared with normal mice, the brain barrier of AD rats is damaged, which may lead to corresponding changes in the brain barrier transport mechanism and affect the clearance of Aβ in the brain, and the steady-state mechanisms existing in the brain barrier, such as secretions and receptors thereof. Mediated signaling may also change, and these factors may be involved in the formation and progression of AD.

Key words

Alzheimer’s disease / Blood brain barrier / Blood cerebrospinal fluid barrier / Choroid plexus / Proliferation / Vascular nerve unit / Immunofluorescence / Mouse

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

CUI Zhan-jun LIU Fang ZHAO Kai-bing LI Bing-mei LIU Zhong-hua. Brain barrier structure of APPSWE Tg2576 mice[J]. Acta Anatomica Sinica. 2018, 49(5): 571-578 https://doi.org/10.16098/j.issn.0529-1356.2018.05.002

References

［1］ Querfurth HW, LaFerla FM. Alzheimer’s disease［J］. N Engl J Med, 2010, 362（4）:329-344.

［2］ Alonso Vilatela ME, López-López M, YescasGómez P. Genetics of Alzheimer’s disease ［J］. Arch Med Res, 2012,43(8):622-631.

［3］ Kim DH, Yeo SH, Park JM, et al. Genetic markers for diagnosis and pathogenesis of Alzheimer’s disease［J］. Gene, 2014,545(2):185-193.

［4］ Steinberg S, Stefansson H, Jonsson T, et al. Loss-of-function variants in ABCA7 confer risk of Alzheimer’s disease［J］. Nat Genet, 2015,47(5):445-447.

［5］ Lambert JC, Ibrahim-Verbaas CA, Harold D, et al. Meta-analysis of 74046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease［J］. Nat Genet, 2013,45(12):1452-1458.

［6］ Zuroff L, Daley D, Black KL,et al. Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes［J］.Cell Mol Life Sci, 2017, 74(12): 2167-2201.

［7］ Abbott NJ, Patabendige AA, Dolman DE, et al. Structure and function of the blood-brain barrier［J］. Neurobiol Dis, 2010, 37(1):13-25.

［8］ Villeda SA, Luo J, Mosher KI, et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function［J］. Nature, 2011, 477(3762):90-94.

［9］ Liu YJ, Guo DW, Tian L, et al. Peripheral T cells derived from Alzheimer’s disease patients overexpress CXCR2 contributing to its transendothelial migration, which is microglial NF-alpha-dependent［J］. Neurobiol Aging, 2010, 31(2):175-188.

［10］Gosselet F, Saint-Pol J, Candela P, et al. Amyloid-beta peptides, Alzheimer’s disease and the blood-brain barrier［J］. Curr Alzheimer Res, 2013,10(10):1015-1033.

［11］Spector R, Keep RF, Robert SS, et al. A balanced view of choroid plexus structure and function: focus on adult humans［J］. Exp Neurol, 2015,267:78-86.

［12］Chalbot S, Zetterberg H, Blennow K, et al. Blood-cerebrospinal fluid barrier permeability in Alzheimer’s disease［J］. J Alzheimers Dis, 2011,25(3):505-515.

［13］Krzyzanowska A, Carro E. Pathological alteration in the choroid plexus of Alzheimer’s disease: implication for new therapy approaches［J］. Front Pharmacol, 2012,3:75.

［14］Silverberg GD, Mayo M, Saul T, et al. Alzheimer’s disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis［J］. Lancet Neurol, 2003,2(8):506-511.

［15］Gonzalez-Marrero Ⅰ, Gimenez-Llort L, Johanson CE, et al. Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer’s disease［J］. Front Cell Neurosci, 2015,9:17.

［16］Begley DJ, Brightman MW. Structural and functional aspects of the blood-brain barrier［J］. Prog Drug Res, 2003, 61:39-78.

［17］Pardridge WM, Eisenberg J, Yang J. Human blood-brain barrier insulin receptor［J］. J Neurochem, 1985, 44(6):1771-1778.

［18］Zhang Y, Pardridge WM. Rapid transferrin efflux from brain to blood across the blood-brain barrier［J］. J Neurochem, 2001, 76(5):1597-1600.

［19］Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders［J］. Neuron, 2008, 57(2):178-201.

［20］Daneman R. The blood-brain barrier in health and disease［J］. Ann Neurol, 2012,72(5):648-672.

［21］Zhong Z, Deane R, Ali Z, et al. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration［J］. Nat Neurosci, 2008,11(4):420-422.

［22］Bell RD, Winkler EA, Sagare AP, et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging［J］. Neuron, 2010, 68(3):409-427.

［23］Daneman R, Zhou L, Kebede AA, et al. Pericytes are required for blood-brain barrier integrity during embryogenesis［J］. Nature, 2010, 468(7323):562-566.

［24］Li F, Lan Y, Wang Y, et al. Endothelial Smad4 maintains cerebrovascular integrity by activating N-cadherin through cooperation with Notch［J］. Dev Cell, 2011,20(3):291-302.

［25］Dziegielewska KM, Ek J, Habgood MD, et al. Development of the choroid plexus［J］. Microsc Res Tech, 2001, 52(1):5-20.

［26］Saunders NR, Daneman R, Dziegielewska KM, et al. Transporters of the bloodbrain and blood-CSF interfaces in development and in the adult［J］. Mol Aspects Med, 2013, 34(2-3):742-752.

［27］Speake T, Whitwell C, Kajita H, et al. Mechanisms of CSF secretion by the choroid plexus［J］. Microsc Res Tech, 2001,52(1):49-59.

［28］de Lange EC. Potential role of ABC transporters as a detoxification system at the blood-CSF barrier［J］. Adv Drug Deliv Rev,2014,56(12):1793-1809.

［29］Bergen AA, Kaing S, ten Brink JB, et al. Gene expression and functional annotation of human choroid plexus epithelium failure in Alzheimer’s disease［J］. BMC Genomics, 2015,16:956.

［30］Serot JM, Béné MC, Foliguet B, et al. Morphological alterations of the choroid plexus in late-onset Alzheimer’s disease［J］. Acta Neuropathol, 2000, 99(2):105-108.